Search

Displaying results 7881 - 7890 of 10000 in total
  1. Drug

    Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (propiolactone inactivated)

    go.drugbank.com/drugs/DB11042
    ApprovedWithdrawn

    Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen

  2. Drug

    Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (propiolactone inactivated)

    go.drugbank.com/drugs/DB11046
    ApprovedWithdrawn

    Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen

  3. Indication

    Unexplained Chronic Cough

    go.drugbank.com/conditions/DBCOND0153675
    Drugs: Gefapixant
    Synonyms: Cough, NOS, Cough symptom NOS
  4. Indication

    Central Precocious Puberty (CPP)

    go.drugbank.com/conditions/DBCOND0040295
    Drugs: Histrelin · Leuprolide · Nafarelin
    Synonyms: Sexual precocity NOS, Sexual precocity, NOS
  5. Drug

    Antimony potassium tartrate

    go.drugbank.com/drugs/DB15587
    Experimental

    It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.

  6. Drug

    Etorphine

    go.drugbank.com/drugs/DB01497
    ExperimentalIllicitVet approved

    In certain countries, etorphine is classified as a Schedule 1 drug and hence, in these countries, it can be used legally only by health professionals and for research purposes.

  7. Drug

    Brecanavir

    go.drugbank.com/drugs/DB04887
    Investigational

    Brecanavir (VX-385) an orally active aspartic protease inhibitor (PI), under investigation by Vertex and GlaxoSmithKline for the treatment of HIV.

  8. Drug

    MVC-COV1901

    go.drugbank.com/drugs/DB15854
    Investigational

    MVC-COV1901 is a vaccine candidate developed and commercialized by Medigen Vaccine Biologics Corporation. The vaccine candidate contains a perfusion form of the SARS-Cov2 recombinant spike protein.

  9. Drug

    SAR445136

    go.drugbank.com/drugs/DB17708
    Investigational

    It consists of autologous CD34+ hematopoietic stem precursor cells (HSPC) modified ex vivo by zinc finger nucleases (ZFN) that target the BCL11A gene erythroid-specific enhancer (ESE) to increase endogenous

  10. Drug

    R-348

    go.drugbank.com/drugs/DB06321
    Investigational

    Synonyms: 5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N'-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine